|
1
|
Di Bisceglie AM, Rustgi VK, Hoofnagle JH,
Dusheiko GM and Lotze MT: NIH conference, Hepatocellular carcinoma.
Ann Intern Med. 108:390–401. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen JG and Zhang SW: Liver cancer
epidemic in China: past, present and future. Semin Cancer Biol.
21:59–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poupon R, Fartoux L and Rosmorduc O:
Therapeutic advances in hepatocellular carcinoma. Bull Acad Natl
Med. 192:23–31. 2008.(In French). PubMed/NCBI
|
|
4
|
Bosch FX, Ribes J and Borràs J:
Epidemiology of primary liver cancer. Semin Liver Dis. 19:271–285.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Forner A, Hessheimer AJ, Isabel Real M and
Bruix J: Treatment of hepatocellular carcinoma. Crit Rev Oncol
Hematol. 60:89–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakobs TF, Hoffmann RT, Tatsch K, Trumm C
and Reiser MF: Therapy response of liver tumors after selective
internal radiation therapy. Radiologe. 48:839–849. 2008.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fadeel B and Orrenius S: Apoptosis: a
basic biological phenomenon with wide-ranging implications in human
disease. J Intern Med. 258:479–517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jacobson MD, Weil M and Raff MC:
Programmed cell death in animal development. Cell. 88:347–354.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kerr JF: Shrinkage necrosis: a distinct
mode of cellular death. J. Pathol. 105:13–20. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Searle J, Kerr JF and Bishop CJ: Necrosis
and apoptosis: distinct modes of cell death with fundamentally
different significance. Pathol Annu. 17:229–259. 1982.PubMed/NCBI
|
|
12
|
Rich T, Watson CJ and Wyllie A: Apoptosis:
the germs of death. Nat Cell Biol. 1:E69–E71. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu W and Kavanagh JJ: Anticancer therapy
targeting the apoptotic pathway. Lancet Oncol. 4:721–729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McCulloch M, See C, Shu XJ, et al:
Astragalus-based Chinese herbs and platinum-based chemotherapy for
advanced non-small-cell lung cancer: meta-analysis of randomized
trials. J Clin Oncol. 24:419–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mok TS, Yeo W, Johnson PJ, et al: A
double-blind placebo-controlled randomized study of Chinese herbal
medicine as complementary therapy for reduction of
chemotherapy-induced toxicity. Ann Oncol. 18:768–774. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lorey S, Porzel A and Ripperger H: Steroid
alkaloid glycosides from Solanum coccineum. Phytochemistry.
41:1633–1635. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Son YO, Kim J, Lim JC, Chung Y, Chung GH
and Lee JC: Ripe fruit of Solanum nigrum L. inhibits cell growth
and induces apoptosis in MCF-7 cells. Food Chem Toxicol.
41:1421–1428. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Li Q, Feng T and Li K: Aqueous
extract of Solanum nigrum inhibit growth of cervical carcinoma
(U14) via modulating immune response of tumor bearing mice and
inducing apoptosis of tumor cells. Fitoterapia. 79:548–556. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu K, Kobayashi H, Dong A, Jing Y, Iwasaki
S and Yao X: Antineoplastic agents. III: Steroidal glycosides from
Solanum nigrum. Planta Med. 65:35–38. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shiu LY, Chang LC, Liang CH, Huang YS,
Sheu HM and Kuo KW: Solamargine induces apoptosis and sensitizes
breast cancer cells to cisplatin. Food Chem Toxicol. 45:2155–2164.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu T, Zhu W, Yang X, et al: Detection of
apoptosis based on the interaction between annexin V and
phosphatidylserine. Anal Chem. 81:2410–2413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lam W, Bussom S, Guan F, et al: The
four-herb Chinese medicine PHY906 reduces chemotherapy-induced
gastrointestinal toxicity. Sci Trans Med. 2:45ra592010.
|
|
23
|
Chen W, Lim CE, Kang HJ and Liu J: Chinese
herbal medicines for the treatment of type A H1N1 influenza: a
systematic review of randomized controlled trials. PLoS One.
6:e280932011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding X, Zhu FS, Li M and Gao SG: Induction
of apoptosis in human hepatoma SMMC-7721 cells by solamargine from
Solanum nigrum L. J Ethnopharmacol. 139:599–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun L, Zhao Y, Li X, Yuan H, Cheng A and
Lou H: A lysosomal-mitochondrial death pathway is induced by
solamargine in human K562 leukemia cells. Toxicol In Vitro.
24:1504–1511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Zhao Y, Wu WK, Liu S, Cui M and Lou
H: Solamargine induces apoptosis associated with p53
transcription-dependent and transcription-independent pathways in
human osteosarcoma U2OS cells. Life Sci. 88:314–321. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baggett D, Nakaya MA, McAuliffe M,
Yamaguchi TP and Lockett S: Whole cell segmentation in solid tissue
sections. Cytometry A. 67:137–143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dormann D, Libotte T, Weijer CJ and
Bretschneider T: Simultaneous quantification of cell motility and
protein-membrane-association using active contours. Cell Motil
Cytoskeleton. 52:221–230. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu B, Cheng HD, Huang J, et al:
Probability density difference-based active contour for ultrasound
image segmentation. Pattern Recognit. 43:2028–2042. 2010.
View Article : Google Scholar
|
|
30
|
Beresford MJ, Wilson GD and Makris A:
Measuring proliferation in breast cancer:practicalities and
applications. Breast Cancer Res. 8:2162006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leonardi E, Girlando S, Serio G, et al:
PCNA and Ki67 expression in breast carcinoma: correlations with
clinical and biological variables. J Clin Pathol. 45:416–419. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scholzen T and Gerdes J: The Ki-67
protein: from the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang N, Wang X, Huo Q, et al: The
oncogene metadherin modulates the apoptotic pathway based on the
tumor necrosis factor superfamily member TRAIL (Tumor Necrosis
Factor-related Apoptosis-inducing Ligand) in breast cancer. J Biol
Chem. 288:9396–9407. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chan SL and Yu VC: Proteins of the bcl-2
family in apoptosis signalling: from mechanistic insights to
therapeutic opportunities. Clin Exp Pharmacol Physiol. 31:119–128.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reyes-Zurita FJ, Rufino-Palomares EE,
Lupiáñez JA and Cascante M: Maslinic acid, a natural triterpene
from Olea europaea L, induces apoptosis in HT29 human colon-cancer
cells via the mitochondrial apoptotic pathway. Cancer Lett.
273:44–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Adams JM and Cory S: The Bcl-2 protein
family: arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang N, Kong X, Yan S, Yuan C and Yang Q:
Huaier aqueous extract inhibits proliferation of breast cancer
cells by inducing apoptosis. Cancer Sci. 101:2375–2383. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Antonsson B: Bax and other pro-apoptotic
Bcl-2 family ‘killer-proteins’ and their victim the mitochondrion.
Cell Tissue Res. 306:347–361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Crompton M: Bax, Bid and the
permeabilization of the mitochondrial outer membrane in apoptosis.
Curr Opin Cell Biol. 12:414–419. 2000. View Article : Google Scholar : PubMed/NCBI
|
